Capabilities for transdisciplinary research

Problems framed as societal challenges have provided fresh impetus for transdisciplinary research. In response, funders have started programmes aimed at increasing transdisciplinary research capacity. However, current programme evaluations do not adequately measure the skills and characteristics of individuals and collectives doing this research. Addressing this gap, we propose a systematic framework for evaluating transdisciplinary research based on the Capability Approach, a set of concepts designed to assess practices, institutions, and people based on public values. The framework is operationalized through a mixed-method procedure which evaluates capabilities as they are valued and experienced by researchers themselves. The procedure is tested on a portfolio of ‘pump-priming’ research projects in the UK. We find these projects are sites of capability development in three ways: through convening cognitive capabilities required for academic practice; cultivating informal tacit capabilities; and maintaining often unacknowledged backstage capabilities over durations that extend beyond the lifetime of individual projects. Directing greater attention to these different modes of capability development in transdisciplinary research programmes may be useful formatively in identifying areas for ongoing project support, and also in steering research system capacity towards societal needs

What is robotics made of? The interdisciplinary politics of robotics research

Under framings of grand challenges, robotics has been proposed as a solution to a wide range of societal issues such as road safety, ageing society, economic productivity and climate change. However, what exactly is robotics research? From its inception, robotics has been an inherently interdisciplinary field, bringing together diverse domains such as engineering, cognitive science, computer science and, more recently, knowledge from social sciences and humanities. Previous research on interdisciplinarity shows that this mode of knowledge production is often driven by societal concerns and political choices. The politics of who gets to make these choices and on what terms is the focus of empirical research in this paper. Using a novel mixed-method approach combining bibliometrics, desk-based analysis and fieldwork, this article builds a narrative of interdisciplinarity at the UK’s largest public robotics lab, the Bristol Robotics Laboratory. This paper argues for the recognition of the plural ways of knowing interdisciplinarity. From citation analysis, through tracing of the emerging fields and disciplines, to, finally, the investigation of researchers’ experiences; each method contributes a distinct and complementary outlook on “what robotics is made of”. While bibliometrics allows visualising prominent disciplines and keywords, document analysis reveals influential and missing stakeholders. Meanwhile, fieldwork explores the logics underpinning robotics and identifies the capabilities necessary to perform the research. In doing so, the paper synthesises plural ways of locating politics in interdisciplinary research and provides recommendations for enabling “structural preparedness for interdisciplinarity”

Workshop: Lassoing unicorns: how to map capabilities for better interdisciplinary research

Sometimes doing interdisciplinary work feels like trying to lasso unicorns. Working with big players from foreign disciplines and interdepartmental drifters. Negotiating over language and frameworks. Agreeing common research questions. All the while trying to gather data and do good work. Building on methods developed in ESRC and Horizon 2020 funded projects on interdisciplinary research, this workshop will: a) introduce the concept interdisciplinary capabilities - the disciplinary skills and informal aptitudes needed for people like environmental engineers, ecological economists and machine learning developers to work well together. b) present a mixed-method approach to mapping capabilities using bibliometric analysis and interviews. c) offer hands-on reflexive exercises on personal ‘capability mapping’, tailored to workshop participants The session will help scholars of all levels recognise power and knowledge in research and identify opportunities to steer that research together

Three-Dimensional two-pion source image from Pb+Pb Collisions at Sqrts_NN=17.3 GeV: New constraints for source breakup dynamics

Source imaging methodology is used to provide a three-dimensional two-pion source function for mid-rapidity pion pairs with $p_T<70$ MeV/c in central ($0-7$) Pb+Pb collisions at $\sqrt s_{NN}$=17.3 GeV. Prominent non-Gaussian tails are observed in the pion pair transverse momentum (outward) and in the beam (longitudinal) directions. Model calculations reproduce them with the assumption of Bjorken longitudinal boost invariance and transverse flow blast-wave dynamics coupled with "outside-in burning" in the transverse direction; they also yield a proper time for breakup and emission duration for the pion source.Comment: Six pages 4 figs. Submitted for publicatio

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome